CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ZURA

Tibulizumab Dose A

Phase 2
Zura Bio Ltd (ZURA)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '26
ZURAPhase 2

Tibulizumab Dose A Phase 2 Est. Readout

Tibulizumab Dose A
Nov 2026~STALE
CT.gov
00%
Competitive Landscape

0 competitors in Hidradenitis Suppurativa (HS)

View Full Landscape
Drug Information

Target Indication

Hidradenitis Suppurativa (HS)

Clinical Trial

NCT06993610

Last updated: 1/11/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.